If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Directorate Change

6 Jun 2006 07:02

Synexus Clinical Research PLC06 June 2006 Synexus Clinical Research Plc ("the Company") Directorate change Synexus Clinical Research Plc is pleased to announce the appointment of MalcolmHughes (aged 52) as Non-Executive Director with immediate effect. Malcolm is currently Chief Executive of Greenman Group plc ("Greenman"), aprivate industrial company which supplies printer cartridges to European officesupplies distributors from its manufacturing base in Bulgaria. Prior toGreenman, he was Chief Executive of Oasis Healthcare Plc for four years duringwhich Oasis grew from a small regional business to become the leading dentalpractice owner/operator in the UK with turnover of over £70m. His previousexperience includes senior management roles at Chloride Group plc, LadbrokeGroup plc and Management Consulting Group plc. Commenting on the appointment, Michael Fort, chief executive of Synexus said : " I am delighted to welcome Malcolm to the Synexus board. He brings with himconsiderable knowledge and expertise, not only within the healthcare industrybut also particular experience of business operations within the emergingeconomies of Eastern Europe where Synexus has established a foothold and fromwhich we aim to expand rapidly. We look forward to benefiting from hiscontribution to the development and implementation of our growth strategy." Malcolm Hughes commented: "I am delighted to be joining Synexus at a time when it is seeking to build onits recent AIM flotation through expansion of its operations in the UK andinternationally. Its unique business model offers a strong proposition to globalpharmaceutical companies as they aim to develop more cost-effective methods oftrialling new drug treatments." Additional Information The following is a complete list of Mr Hughes' directorships as required underSchedule 2(g) of the AIM Rules: Current Previous in last 5 yearsGreenman Group plc Oasis Healthcare PlcGreenman UK Limited Oasis Dental Care LimitedGreenman Europe BV The Dencare Management Group LimitedK2 Supplies Limited Dencare Management LimitedPaprika Services Limited Dencare Financial Services LimitedBetforum UK Limited Dencare Developments Limited Dencare Implant Centres Limited Ora Dental Group Holdings Limited Ora Dental Group Limited Ora EBT Trustee Limited Inhoco 978 Limited Inhoco 979 Limited There is no further information required to be disclosed under Schedule 2(g) ofthe AIM Rules. For further information: Michael Fort, Chief Executive, Synexus Clinical Research PLC 01257 230 723 Zoe Biddick, Biddicks 020 7448 1000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Oct 201510:35 amRNSDirector/PDMR Shareholding
9th Oct 20157:00 amRNSBoard Changes
7th Aug 201510:05 amRNSHolding(s) in Company
21st Jul 20157:00 amRNSInterim results
3rd Jul 20157:00 amRNSNotification of Interim Results
2nd Jun 20155:54 pmRNSHolding(s) in Company
19th May 20151:00 pmRNSResult of AGM
19th May 20157:00 amRNSAGM Statement
13th May 20157:00 amRNSMajor Contract Expansion in the Far East
20th Apr 20157:00 amRNSDirector/PDMR Shareholding
14th Apr 201511:19 amRNSNotice of AGM & Publication of Annual Report
13th Apr 20151:28 pmRNSHolding(s) in Company
7th Apr 20159:13 amRNSDirector/PDMR Shareholding
2nd Apr 20157:00 amRNSSynergy 3 chosen for Jakarta International Airport
1st Apr 20157:26 amRNSDirector/PDMR Shareholding
30th Mar 20154:12 pmRNSAward of Options and Directors' Shareholdings
20th Mar 20158:55 amRNSHolding(s) in Company
10th Mar 20155:02 pmRNSHolding(s) in Company
10th Mar 20157:03 amRNSPreliminary Results
10th Feb 20157:00 amRNSNotification of Final Results
9th Feb 20153:45 pmRNSHolding(s) in Company
6th Feb 20153:08 pmRNSHolding(s) in Company
30th Jan 20157:00 amRNSBoard Changes
14th Jan 201511:21 amRNSHolding(s) in Company
6th Jan 20154:21 pmRNSHolding(s) in Company
31st Dec 20148:32 amRNSHolding(s) in Company
31st Dec 20148:29 amRNSHolding(s) in Company
31st Dec 20148:26 amRNSHolding(s) in Company
23rd Dec 20142:58 pmRNSHolding(s) in Company
16th Dec 20147:00 amRNSYear End Trading Update
10th Nov 20145:16 pmRNSHolding(s) in Company
10th Nov 20145:10 pmRNSHolding(s) in Company
7th Nov 201411:58 amRNSHolding(s) in Company
6th Nov 20144:33 pmRNSHolding(s) in Company
6th Nov 20147:00 amRNSBoard Appointment
28th Oct 20148:49 amRNSHolding(s) in Company
27th Oct 20147:00 amRNSTrading Update and Board Changes
6th Oct 20142:06 pmRNSDirector/PDMR Shareholding
14th Aug 201410:22 amRNSHolding(s) in Company
12th Aug 20143:09 pmRNSHolding(s) in Company
30th Jul 20143:44 pmRNSHolding(s) in Company
29th Jul 20147:00 amRNSInterim Results
15th Jul 20145:24 pmRNSHolding(s) in Company
3rd Jul 20148:18 amRNSHolding(s) in Company
30th Jun 20147:00 amRNSEUR4 million Berlin Transport Contract Extension
26th Jun 20143:31 pmRNSHolding(s) in Company
25th Jun 20147:00 amRNSTrading Statement
6th Jun 20142:56 pmRNSDirector/PDMR Shareholding
28th May 20147:00 amRNSLaunch of Synergy 3 command and control platform
21st May 20147:00 amRNSPublication of Industry Research Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.